Browse by Academic Unit (A-Z)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators Name | Item Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items at this level: 145.

A

Adams, M, Calvert, AH, Carmichael, J et al. (20 more authors) (1998) Chemotherapy for ovarian cancer - a consensus statement on standard practice. British Journal of Cancer, 78 (11). pp. 1404-1406. ISSN 0007-0920

Adams, RA, Brown, E, Brown, L et al. (13 more authors) (2016) FOCUS4-D: Results from a randomised, placebo controlled trial (RCT) of AZD8931 (an inhibitor of signalling by HER1, 2, and 3) in patients (pts) with advanced or metastatic colorectal cancer (aCRC) in tumours that are wildtype (wt) for BRAF, PIK3CA, KRAS & NRAS. In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016, Copenhagen. Oxford University Publishing .

Ahmed, K, Kyte, D, Keeley, T et al. (15 more authors) (2016) Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol. BMJ Open, 6 (9). e012863. ISSN 2044-6055

Akbulut, Y, Gaunt, HJ, Muraki, K et al. (12 more authors) (2015) (−)-Englerin A is a Potent and Selective Activator of TRPC4 and TRPC5 Calcium Channels. Angewandte Chemie International Edition, 54 (12). pp. 3787-3791. ISSN 1433-7851

Alexander, S, Bridges, J, Kalsi, T et al. (3 more authors) (2019) Improving outcomes for older people with cancer – A workshop of the UK National Cancer Research Institute. Journal of Geriatric Oncology, 10 (3). pp. 378-381. ISSN 1879-4068

Appelt, AL orcid.org/0000-0003-2792-9218, Bentzen, SM and Vogelius, IR (2016) EP-1724: Model-based effect estimates reduce sample-size requirements in randomized trials of proton therapy. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S806-S807.

Appelt, AL orcid.org/0000-0003-2792-9218 and Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 (2016) Technological advances in radiotherapy of rectal cancer: opportunities and challenges. Current Opinion in Oncology, 28 (4). pp. 353-358. ISSN 1040-8746

Appelt, AL orcid.org/0000-0003-2792-9218, Teo, M, Christophides, D et al. (5 more authors) (2017) EP-1748: Mesorectal-only irradiation for early stage rectal cancer: Target volumes and dose to organs at risk. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S962-S963.

B

Banks, RE, Gearing, AJ, Hemingway, IK et al. (3 more authors) (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. British Journal of Cancer, 68 (1). pp. 122-124. ISSN 0007-0920

Beasley, M, Brown, S, McNair, H et al. (5 more authors) (2019) The advanced radiotherapy network (ART-NET) UK lung stereotactic ablative radiotherapy survey: national provision and a focus on image guidance. The British Journal of Radiology. ISSN 0007-1285

Birch, RJ orcid.org/0000-0003-1579-1397, Taylor, JC orcid.org/0000-0002-2518-5799, Downing, A orcid.org/0000-0002-0335-7801 et al. (6 more authors) (2019) Rectal cancer in old age –is it appropriately managed? Evidence from population-based analysis of routine data across the English national health service. European Journal of Surgical Oncology. ISSN 0748-7983

Bolla, M, Henry, A orcid.org/0000-0002-5379-6618, Mason, M et al. (1 more author) (2019) The role of radiotherapy in localised and locally advanced prostate cancer. Asian Journal of Urology, 6 (2). pp. 153-161. ISSN 2214-3882

Boulton, A, Boyd, P, Cheng, KK et al. (346 more authors) (2000) The United Kingdom Childhood Cancer Study: objectives, materials and methods. British Journal of Cancer, 82 (5). pp. 1073-1102. ISSN 1532-1827

Brown, PJ, Hyland, R, Quyn, AJ et al. (5 more authors) (2019) Current concepts in imaging for local staging of advanced rectal cancer. Clinical Radiology. ISSN 0009-9260

Brown, S, Van Herk, M, Chuter, R et al. (18 more authors) (2018) Advanced Radiotherapy Technologies Network in the UK (ART-NET) - focus on lung cancer. In: Lung Cancer. 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin, Ireland. Elsevier , S60-S60.

C

Cameron, DA, Anderson, A, Toy, E et al. (9 more authors) (2002) Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer? British Journal of Cancer, 87 (12). pp. 1365-1369. ISSN 0007-0920

Chadi, SA, Malcomson, L, Ensor, J et al. (30 more authors) (2018) Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. The Lancet Gastroenterology and Hepatology, 3 (12). pp. 825-836. ISSN 2468-1253

Choudhury, A, Chen, RC, Henry, A orcid.org/0000-0002-5379-6618 et al. (4 more authors) (2019) STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer? International Journal of Radiation Oncology*Biology*Physics, 104 (1). pp. 33-35. ISSN 0360-3016

Christodoulou, M, Hodgson, C, Zeniou, A et al. (5 more authors) (2017) OC-0124: Outcomes of concurrent chemo-radiotherapy in elderly patients with advanced bladder cancer. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S57-S58.

Christodoulou, M, Reeves, KJ, Hodgson, C et al. (6 more authors) (2018) Outcomes of radiosensitisation in elderly patients with advanced bladder cancer. Radiotherapy and Oncology, 129 (3). pp. 499-506. ISSN 0167-8140

Christophides, D, Appelt, AL orcid.org/0000-0003-2792-9218, Lilley, J et al. (1 more author) (2017) PO-0853: A method for automatic selection of parameters in NTCP modelling. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S463-S464.

Christophides, D, Gilbert, A, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (3 more authors) (2017) OC-0255: Practical use of principal component analysis in radiotherapy planning. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S129-S130.

Co, JL, Swain, M, Murray, LJ orcid.org/0000-0003-0658-6455 et al. (7 more authors) (2019) Meningioma Screening with MRI in Childhood Leukemia Survivors Treated with Cranial Radiation. International journal of Radiation Oncology*Biology*Physics, 104 (3). pp. 640-643. ISSN 0360-3016

Collinson, K, Murray, MJ, Orsi, NM et al. (5 more authors) (2014) Age-related biological features of germ cell tumors. Genes, Chromosomes and Cancer, 53 (3). pp. 215-227. ISSN 1045-2257

Cook, N, Basu, B, Smith, D-M et al. (16 more authors) (2018) A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer, 118 (6). pp. 793-801. ISSN 0007-0920

Cortés, J, Rugo, HS, Awada, A et al. (16 more authors) (2017) Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial. Breast Cancer Research and Treatment, 165 (2). pp. 329-341. ISSN 0167-6806

Crabb, SJ, Martin, K, Abab, J et al. (21 more authors) (2017) COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. European Journal of Cancer, 87. pp. 75-83. ISSN 0959-8049

Cross, W, Kovac, M, Mustonen, V et al. (53 more authors) (2018) The evolutionary landscape of colorectal tumorigenesis. Nature Ecology & Evolution, 2 (10). pp. 1661-1672. ISSN 2397-334X

Cull, A, Gould, A, House, A orcid.org/0000-0001-8721-8026 et al. (5 more authors) (2001) Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. British Journal of Cancer, 85 (12). pp. 1842-1849. ISSN 0007-0920

D

Davidson, M, Chau, I, Cunningham, D et al. (5 more authors) (2017) Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World Journal of Gastrointestinal Oncology, 9 (8). pp. 333-340. ISSN 1948-5204

Dent, J, Hall, GD, Wilkinson, N et al. (5 more authors) (2003) Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation. British Journal of Cancer, 88 (10). pp. 1578-1583. ISSN 0007-0920

Dong, ST, Costa, DS, Butow, PN et al. (10 more authors) (2016) Symptom Clusters in Advanced Cancer Patients: An Empirical Comparison of Statistical Methods and the Impact on Quality of Life. Journal of Pain and Symptom Management, 51 (1). pp. 88-98. ISSN 0885-3924

Donnelly, DW, Donnelly, C, Kearney, T et al. (26 more authors) (2018) Urinary, bowel and sexual health in older men from Northern Ireland. BJU International, 122 (5). pp. 845-857. ISSN 1464-4096

Donnelly, DW, Gavin, A, Downing, A orcid.org/0000-0002-0335-7801 et al. (20 more authors) (2019) Regional variations in quality of survival among men with prostate cancer across the United Kingdom. European Urology. ISSN 0302-2838

Dorling, L, Kar, S, Michailidou, K et al. (12 more authors) (2016) The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity: A case-control study. PLoS ONE, 11 (7). ISSN 1932-6203

Downing, A orcid.org/0000-0002-0335-7801, Glaser, AW, Finan, PJ et al. (7 more authors) (2019) Functional outcomes and health-related quality of life following curative treatment for rectal cancer: A population-level study in England. International Journal of Radiation Oncology*Biology*Physics, 103 (5). pp. 1132-1142. ISSN 0360-3016

Downing, A orcid.org/0000-0002-0335-7801, Morris, EJA orcid.org/0000-0002-1075-6544, Corrigan, N et al. (13 more authors) (2017) High hospital research participation and improved colorectal cancer survival outcomes: a population-based study. Gut, 66 (1). pp. 89-96. ISSN 0017-5749

Downing, A orcid.org/0000-0002-0335-7801, Morris, EJA orcid.org/0000-0002-1075-6544, Richards, M et al. (12 more authors) (2015) Health-related quality of life after colorectal cancer in England: A patient-reported outcomes study of individuals 12 to 36 months after diagnosis. Journal of Clinical Oncology, 33 (6). pp. 616-624. ISSN 0732-183X

Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143, Hounsome, L et al. (23 more authors) (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncology, 20 (3). pp. 436-447. ISSN 1470-2045

Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143, Wilding, S orcid.org/0000-0002-7977-7132 et al. (13 more authors) (2018) Patient-reported outcomes in men with advanced and localised disease: Results from the UK-wide Life After Prostate Cancer Diagnosis study. In: British Journal of Cancer. 2018 NCRI Cancer Conference of National Cancer Research Institute, 04-06 Nov 2018, Glasgow. Nature Publishing Group , p. 11.

E

Eriksen, AHM, Andersen, RF, Nielsen, BS et al. (4 more authors) (2016) Intratumoral heterogeneity of microRNA expression in rectal cancer. PLoS ONE, 11 (6). ISSN 1932-6203

F

Fatayer, H, Sharma, N, Manuel, D et al. (7 more authors) (2016) Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment. European Journal of Surgical Oncology, 42 (7). pp. 965-972. ISSN 0748-7983

Fish, R, Sanders, C, Adams, R et al. (8 more authors) (2018) A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. Lancet Gastroenterology and Hepatology, 3 (12). pp. 865-873. ISSN 2468-1253

Franko, J, Shi, Q, Meyers, JP et al. (17 more authors) (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. The Lancet Oncology, 17 (12). pp. 1709-1719. ISSN 1470-2045

G

Gahlaut, R, Bennett, A, Fatayer, H et al. (7 more authors) (2016) Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist. European journal of cancer, 60. pp. 40-48. ISSN 0959-8049

Georgiou, L, Wilson, DJ, Sharma, N et al. (2 more authors) (2019) A functional form for a representative individual arterial input function measured from a population using high temporal resolution DCE MRI. Magnetic Resonance in Medicine, 81 (3). pp. 1955-1963. ISSN 0740-3194

Gerrish, K, McDonnell, A and Kennedy, F (2013) The development of a framework for evaluating the impact of nurse consultant roles in the UK. Journal of Advanced Nursing, 69 (10). pp. 2295-2308. ISSN 0309-2402

Ghislain, I, Zikos, E, Coens, C et al. (11 more authors) (2016) Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. The Lancet Oncology, 17 (7). e294-e304. ISSN 1470-2045

Gilbert, A, Davidson, S, Velikova, G orcid.org/0000-0003-1899-5942 et al. (1 more author) (2017) SP-0519: Collecting PROs in clinical practice to assess radiotherapy toxicity and develop normal tissue complication probability models. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S275-S275.

Glaser, A, Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143 et al. (17 more authors) (2018) Life after prostate cancer diagnosis: One step beyond. In: Journal of Clinical Oncology. 2018 Genitourinary Cancers Symposium, 08-10 Feb 2018, San Fransisco, USA. American Society of Clinical Oncology , p. 40.

González Martin, A, Oza, AM, Embleton, AC et al. (13 more authors) (2019) Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer. Gynecologic Oncology, 152 (1). pp. 53-60. ISSN 0090-8258

Goranova, T, Ennis, D, Piskorz, AM et al. (24 more authors) (2017) Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium. British Journal of Cancer, 116 (10). pp. 1294-1301. ISSN 0007-0920

Gravis, G, Chanez, B, Derosa, L et al. (19 more authors) (2016) Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era. Urologic Oncology: Seminars and Original Investigations, 34 (4). 167.e17-167.e23. ISSN 1873-2496

Guren, MG, Christensen, HK, Larsen, SG et al. (3 more authors) (2016) Re-RAD-I external beam radiotherapy for pelvic recurrences in rectal cancer patients previously treated with radiotherapy. In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016. Oxford University Press .

H

Hall, M, Gourley, C, Mcneish, I et al. (6 more authors) (2013) Targeted anti-vascular therapies for ovarian cancer: Current evidence. British Journal of Cancer, 108 (2). pp. 250-258. ISSN 0007-0920

Hall, PE, Shepherd, STC, Brown, J et al. (19 more authors) (2019) Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy. European Urology Focus. ISSN 2405-4569

Hardy, J, Smith, I, Cherryman, G et al. (4 more authors) (1990) The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancer. British Journal of Cancer, 62 (4). pp. 684-686. ISSN 0007-0920

Harji, DP, Griffiths, B, Velikova, G orcid.org/0000-0003-1899-5942 et al. (2 more authors) (2016) Systematic review of health-related quality of life in patients undergoing pelvic exenteration. European Journal of Surgical Oncology, 42 (8). pp. 1132-1145. ISSN 0748-7983

Hawsawi, YM, Jove, M, Humphries, M et al. (5 more authors) (2015) Role of Insulin like Growth Factor Binding Proteins and Tamoxifen Resistance in Breast Cancer Epithelial Cells. In: Journal of Pathology. Dublin Pathology 2015. 8th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 23-25 Jun 2015, Dublin, Ireland. Wiley , S19-S19.

Holch, P, Warrington, L orcid.org/0000-0002-8389-6134, Potrata, B et al. (8 more authors) (2016) Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients. Acta Oncologica, 55 (9-10). pp. 1220-1226. ISSN 0284-186X

Holyoake, DL, Ward, E, Grose, D et al. (11 more authors) (2016) A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol. BMC Cancer, 16. 728. ISSN 1471-2407

Horne, B, Newsham, A, Velikova, G orcid.org/0000-0003-1899-5942 et al. (3 more authors) (2016) Development and evaluation of a specifically designed website for haematopoietic stem cell transplant patients in Leeds. European Journal of Cancer Care, 25 (3). pp. 402-418. ISSN 0961-5423

J

Jennings, V, Ilett, EJ orcid.org/0000-0002-9875-0322, Scott, K orcid.org/0000-0002-5790-9579 et al. (10 more authors) (2014) Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International Journal of Cancer, 134 (5). pp. 1091-1101. ISSN 0020-7136

Joffe, JK, Perren, TJ orcid.org/0000-0001-8472-8856, Bradley, C et al. (5 more authors) (1997) A phase II study of recombinant interferon-β (r-hIFN-β 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma. British Journal of Cancer, 75 (3). pp. 423-426. ISSN 0007-0920

Johnston, DL, Sung, L, Stark, D orcid.org/0000-0002-6172-733X et al. (2 more authors) (2016) A systematic review of patient-reported outcome measures of neuropathy in children, adolescents and young adults. Supportive Care in Cancer, 24 (9). pp. 3723-3728. ISSN 0941-4355

Jones, CM, Spencer, K, Hitchen, C et al. (8 more authors) (2019) Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis. Clinical Oncology, 31 (6). pp. 356-364. ISSN 0936-6555

Judson, IR, Calvert, AH, Gore, ME et al. (4 more authors) (1991) Phase II trial of trimelamol in refractory ovarian cancer. British Journal of Cancer, 63 (2). pp. 311-313. ISSN 0007-0920

K

Kennedy, F, Harcourt, D and Rumsey, N (2008) The challenge of being diagnosed and treated for ductal carcinoma in situ (DCIS). European Journal of Oncology Nursing, 12 (2). pp. 103-111. ISSN 1462-3889

L

Lakhani, S, Selby, P, Bliss, JM et al. (3 more authors) (1990) Chemotherapy for malignant melanoma: Combinations and high doses produce more responses without survival benefit. British Journal of Cancer, 61 (2). pp. 330-334. ISSN 0007-0920

Lam, TBL, MacLennan, S, Plass, K et al. (37 more authors) (2019) Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. European Urology, 75 (4). pp. 699-702. ISSN 0302-2838

Ledermann, JA, Embleton, AC, Raja, F et al. (16 more authors) (2016) Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 387 (10023). pp. 1066-1074. ISSN 0140-6736

M

Mason, J, Adiotomre, E, Bownes, P et al. (2 more authors) (2018) Importance of dynamic contrast enhanced magnetic resonance imaging for targeting biopsy and salvage treatments after prostate cancer recurrence. Journal of Contemporary Brachytherapy, 10 (6). pp. 570-572. ISSN 1689-832X

Mason, J, Bownes, P, Carey, B et al. (1 more author) (2015) Comparison of focal boost high dose rate prostate brachytherapy optimisation methods. Radiotherapy and Oncology, 117 (3). pp. 521-524. ISSN 0167-8140

Mason, J, Mamo, A, Al-Qaisieh, B et al. (2 more authors) (2016) Real-time in vivo dosimetry in high dose rate prostate brachytherapy. Radiotherapy and Oncology, 120 (2). pp. 333-338. ISSN 0167-8140

Matheson, L, Wilding, S orcid.org/0000-0002-7977-7132, Wagland, R et al. (10 more authors) (2019) The psychological impact of being on a monitoring pathway for localised prostate cancer: a UK-wide mixed methods study. Psycho-Oncology. ISSN 1057-9249 (In Press)

Mbidde, EK, Selby, PJ, Perren, TJ orcid.org/0000-0001-8472-8856 et al. (6 more authors) (1988) High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. British Journal of Cancer, 58 (6). pp. 779-782. ISSN 0007-0920

Melcher, AA and Sebag-Montefiore, D (2003) Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost. British Journal of Cancer, 88 (9). pp. 1352-1357. ISSN 0007-0920

Moeller, DS, Hoffmann, L, Lutz, CM et al. (10 more authors) (2016) OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2019, Turin, Italy. Elsevier , S259-S259.

Morris, C, Gooding, MJ, Henry, A orcid.org/0000-0002-5379-6618 et al. (1 more author) (2017) EP-1739: The feasibility of atlas-based automatic segmentation of MRI for prostate radiotherapy planning. In: ESTRO 36, Vienna, Austria.

Morris, EJA, Finan, PJ, Spencer, K et al. (7 more authors) (2016) Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service. Clinical Oncology, 28 (8). pp. 522-531. ISSN 0936-6555

Murray, L orcid.org/0000-0003-0658-6455, Mason, J, Henry, AM orcid.org/0000-0002-5379-6618 et al. (4 more authors) (2016) Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer. Radiotherapy and Oncology, 120 (2). pp. 293-299. ISSN 0167-8140

N

Nielsen, TB, Brink, C, Moeller, DS et al. (10 more authors) (2016) EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S916-S917.

Norman, R, Viney, R, Aaronson, NK et al. (12 more authors) (2016) Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 25 (3). pp. 637-649. ISSN 0962-9343

O

Oyebode, JR, Pini, S, Ingleson, E et al. (6 more authors) (2019) Development of an Item Pool for a Needs-Based Measure of Quality of Life of Carers of a Family Member with Dementia. The Patient: Patient Centered Outcomes Research, 12 (1). pp. 125-136. ISSN 1178-1653

P

Papadopoulos, V, Tsapakidis, K, Del Galdo, NAR et al. (6 more authors) (2016) The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer. Clinical Colorectal Cancer, 15 (2). pp. 116-127. ISSN 1533-0028

Patel, N, Henry, A orcid.org/0000-0002-5379-6618 and Scarsbrook, A orcid.org/0000-0002-4243-032X (2018) The value of MR textural analysis in prostate cancer. Clinical Radiology. ISSN 0009-9260

Perren, TJ orcid.org/0000-0001-8472-8856 (2016) Mucinous epithelial ovarian carcinoma. Annals of Oncology, 27 (S1). i53-i57. ISSN 0923-7534

Perren, TJ orcid.org/0000-0001-8472-8856 (1995) Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience. British Journal of Cancer, 72 (4). pp. 1016-1019. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856 (1991) c-erbB-2 oncogene as a prognostic marker in breast cancer. British Journal of Cancer, 63 (3). pp. 328-332. ISSN 0007-0920

Perren, TJ, Selby, PJ, Milan, S et al. (2 more authors) (1990) Etoposide and adriamycin containing combination chemotherapy (HOPE-BLEO) for relapsed Hodgkin’s disease. British Journal of Cancer, 61 (6). pp. 919-923. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856, Wiltshaw, E, Harper, P et al. (6 more authors) (1993) A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. British Journal of Cancer, 68 (6). pp. 1190-1194. ISSN 0007-0920

Pinhel, I, Hills, M, Drury, S et al. (27 more authors) (2012) ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer. Breast Cancer Research, 14 (2). R46. ISSN 1465-5411

Powles, T, Brown, J, Larkin, J et al. (17 more authors) (2016) A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Annals of Oncology, 27 (5). pp. 880-886. ISSN 0923-7534

Powles, T, Lackner, MR, Oudard, S et al. (18 more authors) (2016) Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology, 34 (14). pp. 1660-1668. ISSN 0732-183X

Powles, T, Wheater, M, Din, O et al. (11 more authors) (2016) A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer. European Urology, 69 (3). pp. 450-456. ISSN 0302-2838

R

Ramasamy, S, Murray, LJ orcid.org/0000-0003-0658-6455, Cardale, K et al. (4 more authors) (2019) Quality Assurance Peer Review of Head and Neck Contours in a Large Cancer Centre via a Weekly Meeting Approach. Clinical Oncology, 31 (6). pp. 344-351. ISSN 0936-6555

Rampling, R, Peoples, S, Mulholland, PJ et al. (17 more authors) (2016) A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multi Peptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research, 22 (19). pp. 4776-4785. ISSN 1078-0432

Renehan, AG, Muirhead, R, Berkman, L et al. (3 more authors) (2019) Early stage anal margin cancer: towards evidence-based management. Colorectal Disease. ISSN 1462-8910

Renfro, LA, Goldberg, RM, Grothey A, et al. (24 more authors) (2017) Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database. Journal of Clinical Oncology, 35 (17). pp. 1929-1937. ISSN 0732-183X

Richman, SD orcid.org/0000-0003-3993-5041, Adams, R, Brown, E et al. (14 more authors) (2017) FOCUS4: MAMS Trial Design in Action. Early Closure of FOCUS4-D (Pan-HER 1, 2 and 3 Inhibitor Versus Placebo) in Advanced Colorectal Cancer (aCRC) Patients, with Tumours Wildtype (WT) for KRAS, NRAS, bRAF and PIK3CA. In: Journal of Pathology. Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 Jun 2017, Belfast, Northern Ireland, UK. Wiley , S13-S13.

Rivas, C, Matheson, L, Nayoan, J et al. (5 more authors) (2016) Ethnicity and the prostate cancer experience: a qualitative metasynthesis. Psycho-Oncology, 25 (10). pp. 1147-1156. ISSN 1057-9249

Rodda, S, Sun, F, Henry, A orcid.org/0000-0002-5379-6618 et al. (2 more authors) (2016) EP-1337: PSA Kinetics: HDR prostate brachytherapy boost in combination with external beam radiotherapy. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S625.

Rogers, Z, Elliott, F, Kasparian, NA et al. (3 more authors) (2016) Psychosocial, clinical and demographic features related to worry in patients with melanoma. Melanoma Research, 26 (5). pp. 497-504. ISSN 0960-8931

Rønde, HS, Pløen, J, Wee, L et al. (1 more author) (2016) OC-0472: Patient preference-driven plan optimisation for shared decision making in anal cancer radiotherapy. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S224-S225.

S

Salem, ME, Yin, J, Weinberg, BA et al. (18 more authors) (2018) Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. European Journal of Cancer, 103. pp. 205-213. ISSN 0959-8049

Sandhu, S, Mateo, J, Miranda, S et al. (31 more authors) (2015) Antitumour Activity of the Poly(Adp-Ribose) Polymerase (Parp) Inhibitor Olaparib in Unselected Sporadic Castration Resistant Prostate Cancer (Crpc) in the Toparp Trial. In: Asia-Pacific Journal of Clinical Oncology. ANZUP Annual Scientific Meeting: Redefining Personalised Medicine, 12-14 Jul 2015, Sydney, Australia. Wiley , pp. 28-29.

Santana, MJ, Haverman, L, Absolom, K orcid.org/0000-0002-5477-6643 et al. (4 more authors) (2015) Training clinicians in how to use patient-reported outcome measures in routine clinical practice. Quality of Life Research, 24 (7). pp. 1707-1718. ISSN 0962-9343

Scelo, G, Hofman, JN, Banks, RE et al. (26 more authors) (2016) International cancer seminars: a focus on kidney cancer. Annals of Oncology, 27 (8). pp. 1365-1366. ISSN 0923-7534

Scherman, J, Appelt, AL orcid.org/0000-0003-2792-9218, Yu, J et al. (5 more authors) (2019) Incorporating NTCP into randomized trials of proton versus photon therapy. International Journal of Particle Therapy, 5 (3). pp. 24-32.

Selby, P, Liu, L, Downing, A orcid.org/0000-0002-0335-7801 et al. (10 more authors) (2019) How can clinical research improve European health outcomes in cancer? Journal of Cancer Policy, 20. ARTN 100182. ISSN 2213-5383

Selby, P, Patel, P, Milan, S et al. (7 more authors) (1990) ChlVPP combination chemotherapy for Hodgkin's disease: long-term results. British Journal of Cancer, 62 (2). pp. 279-285. ISSN 0007-0920

Selby, PJ, Powles, RL, Easton, D et al. (6 more authors) (1989) The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. British Journal of Cancer, 59 (3). pp. 434-438. ISSN 0007-0920

Seligmann, J, Wood, H orcid.org/0000-0003-3009-5904, Richman, S orcid.org/0000-0003-3993-5041 et al. (6 more authors) (2017) 545P Epidermal growth factor receptor (EGFR) copy number (CN) as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC). In: Annals of Oncology. 42nd ESMO Congress (ESMO 2017), 08-12 Sep 2017, Madrid, Spain. Oxford University Press , p. 185.

Seligmann, JF, Elliott, F, Richman, SD et al. (7 more authors) (2016) Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer. JAMA oncology, 2 (5). pp. 633-642. ISSN 2374-2437

Seligmann, JF, Fisher, D, Smith, CG et al. (8 more authors) (2016) Exploring outcomes of RAS-mutant (RAS mut) advanced colorectal cancer (aCRC) treated with chemotherapy: Analysis from 2254 patients (pts) in randomised clinical trials (RCTs). In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 03-07 Jun 2016, Chicago, Il. American Society of Clinical Oncology .

Seymour, M orcid.org/0000-0002-2441-9629 (2019) Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer. Acta Oncologica, 58 (3). pp. 326-333. ISSN 0284-186X

Shaikh, F, Murray, MJ, Amatruda, JF et al. (11 more authors) (2016) Paediatric extracranial germ-cell tumours. Lancet Oncology, 17 (4). e149-e162. ISSN 1470-2045

Sharma, RA, Plummer, R, Stock, JK et al. (36 more authors) (2016) Clinical development of new drug-radiotherapy combinations. Nature Reviews Clinical Oncology, 13 (10). pp. 627-642. ISSN 1759-4774

Smyth, E, Rowley, S, Allum, W et al. (17 more authors) (2016) A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948). Annals of Oncology, 27 (suppl_6). LBA26. ISSN 0923-7534

Snee, MP, McParland, L, Collinson, F et al. (10 more authors) (2016) The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot and Feasibility Studies, 2 (1). 5.

Spencer, K orcid.org/0000-0002-6846-4341, van der Velden, JM, Wong, E et al. (6 more authors) (2019) Systematic review of the role of stereotactic radiotherapy for bone metastases. Journal of the National Cancer Institute. ISSN 0027-8874 (In Press)

Spencer, KL orcid.org/0000-0002-6846-4341, Kennedy, MPT, Lummis, KL et al. (5 more authors) (2019) Surgery or radiotherapy for stage I lung cancer? An intention to treat analysis. European Respiratory Journal. ISSN 0903-1936

Stark, D orcid.org/0000-0002-6172-733X, Rosenberg, AR, Johnston, D et al. (5 more authors) (2016) Patient-reported measures of hearing loss and tinnitus in pediatric cancer and hematopoietic stem cell transplantation: A systematic review. Journal of Speech, Language, and Hearing Research, 59 (5). pp. 1247-1252. ISSN 1092-4388

Strauss, VY, Shaw, R, Virdee, PS et al. (13 more authors) (2019) Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine +/- nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2). BMC Cancer, 19. ARTN 121. ISSN 1471-2407

T

Taylor, S, Harley, C orcid.org/0000-0002-8800-4238, Absolom, K orcid.org/0000-0002-5477-6643 et al. (2 more authors) (2016) Breast cancer, sexuality and intimacy: Addressing the unmet need. The Breast Journal, 22 (4). pp. 478-479. ISSN 1075-122X

Taylor, S, Harley, C orcid.org/0000-0002-8800-4238, Takeuchi, E et al. (2 more authors) (2013) Detecting and discussing sexual problems during chemotherapy for breast cancer. Breast Journal, 19 (5). pp. 566-567. ISSN 1075-122X

Thomsen, CB, Appelt, AL orcid.org/0000-0003-2792-9218, Andersen, RF et al. (3 more authors) (2016) The prognostic impact of RAS and RAF serum mutations in localized colon cancer. In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016, Copenhagen, Denmark. Oxford University Press .

Tsang, DS, Murray, L orcid.org/0000-0003-0658-6455, Ramaswamy, V et al. (9 more authors) (2019) Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma. Neuro-Oncology, 21 (4). noy191. pp. 547-557. ISSN 1522-8517

Turnbull, S, West, E, Scott, K orcid.org/0000-0002-5790-9579 et al. (5 more authors) (2017) Revealing potential immune responses (IRs) in patients with advanced colorectal cancer (aCRC) on first line chemotherapy: A prospective study of neutrophil to lymphocyte ratio, immune function and outcome. In: Annals of Oncology. ESMO 2017 Congress, 08-12 Sep 2017, Madrid, Spain. Oxford University Press .

Turnbull, SJ, West, E, Scott, K et al. (3 more authors) (2018) Chemotherapy to reverse diminished immune responses (IRs) associated with a raised neutrophil lymphocyte ratio (NLR) in patients with advanced colorectal cancer (aCRC). In: Journal of Clinical Oncology. American Society of Clinical Oncology, 24 May 2018. American Society of Clinical Oncology .

Twigger, K, Roulstone, V, Kyula, J et al. (14 more authors) (2012) Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer, 12. 368. ISSN 1471-2407

V

Van den Broeck, T, Van den Bergh, RCN, Arfi, N et al. (25 more authors) (2019) Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. European Urology, 75 (6). pp. 967-987. ISSN 0302-2838

W

Wallington, M, Saxon, EB, Bomb, M et al. (11 more authors) (2016) 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. Lancet Oncology, 17 (9). pp. 1203-1216. ISSN 1470-2045

Ward, G, Ramasamy, S, Sykes, JR et al. (11 more authors) (2016) Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma. Clinical Oncology, 28 (10). pp. 655-662. ISSN 0936-6555

Ward, U, Primrose, JN, Finan, PJ et al. (4 more authors) (1993) The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. British Journal of Cancer, 67 (5). pp. 1132-1135. ISSN 0007-0920

Westwood, AC, Bottomley, D, Hemmings, GJ et al. (11 more authors) (2018) Comparison of Mutational Status in the EGFR Pathway Across Four Different Platforms in the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial. In: Journal of Pathology. Maastricht Pathology 2018. 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht. Wiley , S15-S15.

Westwood, AC, Hemmings, GJ, Bottomley, D et al. (7 more authors) (2018) Comparison of Mismatch Repair Protein Expression Between Biopsies and Resections in Advanced Colon Cancer from the Phase II Group of the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial. In: Journal of Pathology. Maastricht Pathology 2018. 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht. Wiley , S26-S26.

Wilding, S orcid.org/0000-0002-7977-7132, Downing, A orcid.org/0000-0002-0335-7801, Wright, P orcid.org/0000-0001-6129-4143 et al. (10 more authors) (2019) Cancer-related symptoms, mental well-being and psychological distress in men diagnosed with prostate cancer treated with Androgen Deprivation Therapy. Quality of Life Research. ISSN 0962-9343

Wilson, EB orcid.org/0000-0002-0441-728X, El-Jawhari, JJ orcid.org/0000-0002-0580-4492, Neilson, AL et al. (4 more authors) (2011) Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity. PLoS ONE, 6 (9). e22842. ISSN 1932-6203

Wintner, LM, Sztankay, M, Aaronson, N et al. (8 more authors) (2016) The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manual. European Journal of Cancer, 68. pp. 73-81. ISSN 0959-8049

Wolff, RF, Ryder, S, Bossi, A et al. (11 more authors) (2015) A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. European Journal of Cancer, 51 (16). pp. 2354-2367. ISSN 0959-8049

Wright, EP, Kiely, MA, Lynch, P et al. (2 more authors) (2002) Social problems in oncology. British Journal of Cancer, 87 (10). pp. 1099-1104. ISSN 0007-0920

Wright, P orcid.org/0000-0001-6129-4143, Wilding, S orcid.org/0000-0002-7977-7132, Watson, E et al. (12 more authors) (2019) Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study. Cancer Epidemiology, 60. pp. 201-207. ISSN 1877-7821

Wyatt, J, Hedley, S, Johnstone, E et al. (7 more authors) (2017) EP-1708: Investigating the reproducibility of geometric distortion measurements for MR-only radiotherapy. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S935-S936.

Z

Zulian, GB, Selby, P, Milan, S et al. (5 more authors) (1989) High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin’s disease. British Journal of Cancer, 59 (4). pp. 631-635. ISSN 0007-0920

This list was generated on Wed Jun 19 04:18:07 2019 BST.